Cuticapil Stem

1,380.00

  • Powered with plant stem cells- Capilia Longa that reactivates the hair growth
  • Strengthens and nourishes the hair roots
Estimated Delivery Between 2024/07/20 - 2024/07/22

Description

Cuticapil Stem Intensive Hair Serum is a stem cells-based hair serum formula used to minimize hair fall and strengthen and nourish the hair roots.

It contains purmed water, caffiene Herbasome, Zemea Propandiol, Procapil, DC 193 C, Capilia Longa, Euxyl PE 901, Cressatine and Ronacare Biotin plus sodium gluconate as active ingredients that work together to prevent hair fall.

Procapil treats various causes of hair loss such as poor or compromised microcirculation of the scalp, follicle atrophy and follicle ageing. Apigenin acts around the hair follicles and enhances blood perfusion to it by increased relaxation of vessels. Biotin Plus enhances the quality of hair and enhances hair growth.

Oleanolic acid inhibits the production of dihydrotestosterone which causes hair loss. Caffeine alters the barrier properties of the top layer of the skin and transport other ingredients deep into the skin where it can effectively treat and reduce hair loss. Cressantine produces keratin for solid and well-structured hair.

Biotinyl-GHK exhibits anti-ageing activity on the hair follicle and keratinocytes and is responsible for the maintenance of a viable root sheath of the hair. This results in an enhanced structure of the hair and its root due to adhesion proteins that hold the hair in the skin, thereby strengthening hair growth.

Use Cuticapil Stem Intensive Hair Serum exactly as advised by the doctor. It is only for external usage. Do not swallow. Exercise caution and do not apply Cuticapil Stem Intensive Hair Serum on to broken skin and scalp that is red, irritated and infected. Avoid contact with eyes.

Brand

TORRENT PHARMACEUTICALS

Torrent Pharma, the flagship Company of Torrent Group is one of the leading pharma companies of the Country. The Company was a pioneer in initiating the concept of niche marketing in India and and today is ranked amongst the leaders in therapeutic segment of cardiovascular (CV), central nervous system (CNS), gastro-intestinal (GI) and women healthcare (WHC). The Company also has significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments. Torrent Pharma's competitive advantage stems from the world-class manufacturing facilities, advanced R & D capabilities, extensive domestic network and a widespread global presence in over 40 countries. The acquisition of Elder Pharma's Indian branded business in 2013, Dermaceutical business of Zyg Pharma in 2015, API plant of Glochem Industries in 2016, women healthcare brands from Novartis and Unichem's Indian branded business along with its Sikkim Plant in 2017 strengthened Torrent Pharma's position in the Indian Pharma market. Torrent Pharma started international acquisitions in 2005 with 90 year old Heumann from Pfizer to enter the German market. Later on purchased ANDA of Monocycline from Ranbaxy for the US Market in 2015. In January 2018, Torrent also acquired Bio-Pharm, Inc. (BPI) a generic pharmaceuticals and OTC Company, based in Levittown Pennsylvania, USA, which also included a US FDA registered manufacturing facility. Torrent Pharma is committed towards “not just healthcare but lifecare.”

Reviews

There are no reviews yet.

Be the first to review “Cuticapil Stem”
Review Now To Get A Discount Coupon For Your Next Purchase!

Your email address will not be published. Required fields are marked *